REFERENCES
1. Kurowecki D, Patlas MN, Haider EA, Alabousi A. Cross-sectional pictorial review of IgG4-related disease. Br J Radiol. 2019;92(1103):20190448.
2. Karim AF, Bansie RD, Rombach SM et al. The treatment outcomes in IgG4-related disease. Neth J Med. 2018;76(6):275-85.
3. Wallace ZS, Perugino C, Matza M et al. Immunoglobulin G4-related Disease. Clin Chest Med. 2019;40(3):583-597.
4. Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77-87.
5. Bhattad PB, Joseph DL, Peterson E. IgG4-Related Disease Manifesting as Hypocomplementemic Tubulointerstitial Nephritis: A Rare Case Report and Literature Review. J Investig Med High Impact Case Rep. Jan-Dec 2020;8:2324709620952213.
6. Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68(8):1310-5.
7. Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9.
8. Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, Yamamoto M et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis Kidney Int. 2010;78(10):1016-23.
9. Boffa JJ, Esteve E, Buob D. Renal involvement in IgG4-related disease. Presse Med. 2020;49(1):104017.
10. Cornell LD. IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):951-3.
11. Watson SJW, Jenkins DAS, Bellamy COS. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol. 2006;30(11):1472-7.
12. Yoneda K, Murata K, Katayama K, Ishikawa E, Fuke H, Yamamoto N, Ito K et al. Tubulointerstitial nephritis associated with IgG4-related autoimmune disease Am J Kidney Dis. 2007;50(3):455-62.
13. Quattrocchio G, Roccatello D. IgG4-related nephropathy. J Nephrol. 2016;29(4):487-93.
14. Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, Raissian Y et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83(3):455-62.
15. Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M. Diagnostic Approach to the Complexity of IgG4-Related Disease. Mayo Clin Proc. 2015;90(7):927-39.
16. Zhang S, Yang Q. Imaging findings of IgG4-related kidney disease without extrarenal organ involvement: A case report. Medicine (Baltimore). 2019;98(34):e16934.
17. Zhang NN, Wang YY, Kong LX, Zou WZ, Dong B. IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review. BMC Nephrol. 2019;20(1):263.
18. Ardila-Suarez O, Abril A, Gómez-Puerta JA. IgG4-related disease: A concise review of the current literature. Reumatol Clin. 2017;13(3):160-6.
19. Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466-75.
20. Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171-7.
21. Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B et al. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients. PLoS One. 2017;12(9):e0183844.